(1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane

C44H71N7O10 — CID 167570126

IUPAC(1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane
SMILESC.CC[C@H]1OC(=O)[C@H](C)C(=O)C[C@@H](O[C@@H]2O[C@H](C)CC(N(C)C)C2O)[C@](C)(OC)C[C@@H](C)CN(C(C)=O)[C@H](C)[C@H]2N(CCCCn3cc(-c4ccccn4)nn3)C(=O)O[C@]12C
InChIInChI=1S/C43H67N7O10.CH4/c1-12-35-43(8)38(49(41(55)60-43)20-16-15-19-48-25-32(45-46-48)31-17-13-14-18-44-31)29(5)50(30(6)51)24-26(2)23-42(7,56-11)36(22-34(52)28(4)39(54)58-35)59-40-37(53)33(47(9)10)21-27(3)57-40;/h13-14,17-18,25-29,33,35-38,40,53H,12,15-16,19-24H2,1-11H3;1H4/t26-,27-,28-,29-,33?,35-,36-,37?,38-,40+,42-,43-;/m1./s1
InChIKeyFUGKEOVNBSDYBN-GOHCRLLJSA-N
MW858.09 g/mol
LogP4.75
Rot. Bonds11

About (1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane

(1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane (PubChem CID 167570126) has the molecular formula C44H71N7O10 and a molecular weight of 858.09 g/mol. Its IUPAC name is (1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane.

Molecular Properties

Compound Name(1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane
PubChem CID167570126
Molecular FormulaC44H71N7O10
Molecular Weight858.09 g/mol
Exact Mass857.53
IUPAC Name(1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane
SMILESC.CC[C@H]1OC(=O)[C@H](C)C(=O)C[C@@H](O[C@@H]2O[C@H](C)CC(N(C)C)C2O)[C@](C)(OC)C[C@@H](C)CN(C(C)=O)[C@H](C)[C@H]2N(CCCCn3cc(-c4ccccn4)nn3)C(=O)O[C@]12C
InChIInChI=1S/C43H67N7O10.CH4/c1-12-35-43(8)38(49(41(55)60-43)20-16-15-19-48-25-32(45-46-48)31-17-13-14-18-44-31)29(5)50(30(6)51)24-26(2)23-42(7,56-11)36(22-34(52)28(4)39(54)58-35)59-40-37(53)33(47(9)10)21-27(3)57-40;/h13-14,17-18,25-29,33,35-38,40,53H,12,15-16,19-24H2,1-11H3;1H4/t26-,27-,28-,29-,33?,35-,36-,37?,38-,40+,42-,43-;/m1./s1
InChIKeyFUGKEOVNBSDYBN-GOHCRLLJSA-N
XLogP4.75
TPSA187.98 Ų
H-Bond Donors1
H-Bond Acceptors15
Rotatable Bonds11
Heavy Atoms61
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500858.09
LogP ≤ 54.75
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze (1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane?
The IUPAC name of (1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane (CID 167570126) is (1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane.
What is the SMILES notation for (1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane?
The canonical SMILES for (1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane is C.CC[C@H]1OC(=O)[C@H](C)C(=O)C[C@@H](O[C@@H]2O[C@H](C)CC(N(C)C)C2O)[C@](C)(OC)C[C@@H](C)CN(C(C)=O)[C@H](C)[C@H]2N(CCCCn3cc(-c4ccccn4)nn3)C(=O)O[C@]12C.
What is the InChIKey of (1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane?
The InChIKey is FUGKEOVNBSDYBN-GOHCRLLJSA-N. The full InChI is InChI=1S/C43H67N7O10.CH4/c1-12-35-43(8)38(49(41(55)60-43)20-16-15-19-48-25-32(45-46-48)31-17-13-14-18-44-31)29(5)50(30(6)51)24-26(2)23-42(7,56-11)36(22-34(52)28(4)39(54)58-35)59-40-37(53)33(47(9)10)21-27(3)57-40;/h13-14,17-18,25-29,33,35-38,40,53H,12,15-16,19-24H2,1-11H3;1H4/t26-,27-,28-,29-,33?,35-,36-,37?,38-,40+,42-,43-;/m1./s1.
What are the key properties of (1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane?
(1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane has a molecular weight of 858.09 g/mol, XLogP of 4.75, 11 rotatable bonds, 1 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,2R,5R,8R,9R,11R,14R,15R)-13-acetyl-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,9,11,14-pentamethyl-16-[4-(4-pyridin-2-yltriazol-1-yl)butyl]-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecane-4,6,17-trione;methane is sourced from PubChem (CID 167570126), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).